Excelimmune's Series A Round

Excelimmune raised a round of funding on May 23, 2007.

Excelimmune is a biopharmaceutical company specializing in the development of recombinant polyclonal antibodies to create novel therapies for treating disease in humans. This next generation technolog…

Articles about Excelimmune's Series A Round: